Related references
Note: Only part of the references are listed.Chasing the storm: Recruiting non-hospitalized patients for a multi-site randomized controlled trial in the United States during the COVID-19 pandemic
Kelly Hu et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Cure models to estimate time until hospitalization due to COVID-19 A case study in Galicia (NW Spain)
Maria Pedrosa-Laza et al.
APPLIED INTELLIGENCE (2022)
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis et al.
LANCET GLOBAL HEALTH (2022)
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
Fiona P. Havers et al.
JAMA INTERNAL MEDICINE (2022)
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?
Dominic L. Sykes et al.
LUNG (2021)
Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Ly-Mee Yu et al.
LANCET (2021)
International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019
Nicole Evangelidis et al.
CRITICAL CARE MEDICINE (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Current Understanding of COVID-19 Clinical Course and Investigational Treatments
Richard B. Aguilar et al.
FRONTIERS IN MEDICINE (2020)
A real-time dashboard of clinical trials for COVID-19
Kristian Thorlund et al.
LANCET DIGITAL HEALTH (2020)
Sample size calculation for a proportional hazards mixture cure model with nonbinary covariates
Yihong Zhan et al.
JOURNAL OF APPLIED STATISTICS (2019)
Validity of composite end points in clinical trials
VM Montori et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)